Showed the highest inhibitory activity against the T cell line-tropic HIV-1 infection through its specific binding to a chemokine receptor CXCR4 (IC₅₀ = 0.18 ± 0.041 nM) and the strongest inhibitory effect on the binding of an anti-CXCR4 monoclonal antibody to CXCR4 (IC₅₀ = 2.3 ± 0.20 nM).
Showed the highest inhibitory activity against the T cell line-tropic HIV-1 infection through its specific binding to a chemokine receptor CXCR4 (IC₅₀ = 0.18 ± 0.041 nM) and the strongest inhibitory effect on the binding of an anti-CXCR4 monoclonal antibody to CXCR4 (IC₅₀ = 2.3 ± 0.20 nM).
| Pack size available | 0.5mg, 1mg |
|---|
